Japanese Japanese

Regular Meeting

KBCCC the 21st Regular Meeting - Concluded (10/27/2014 Updated)


Concluded! 21st Regular Meeting pre-survey results will be published soon on this website (members only access)

The 21st Kyoto Breast Cancer Consensus Conference
~Anticancer Drug Treatment of HER2 Negative Recurrent Breast Cancer~

Date: Saturday 8 November 2014, 14:45~ * Registration starts at 14:30
Venue: Shiran Hall

1. Opening Address    15:00~15:05     Dr. Ryuji Okamura, Department of  Surgery, Yamato Takada Municipal Hospital
                   

2. Mini Lecture   15:05~15:35    “Individualized Medicine of Recurrent Growth”
Moderator: Dr. Takashi Okino, Department of  Surgery, Kohka Public Hospital
Lecturer: Dr. Naoki Niikura, Department of Target Therapy Oncology, Kyoto University Graduate School of Medicine
       
3. Reporting the Result of the 21st Questionnaire    15:35~15:45
Dr. Masahiro Takada, Department of Breast Surgery, Kyoto  University Graduate School of Medicine
                   
4. Info from BORN-BB    15:45~15:55
Dr. Masahiro Kawashima, Department of Breast Surgery, Kyoto University Graduate School of Medicine
                 
5. Reporting the Result of Cohort Study    15:55~16:05   Dr. Takeshi Kotake, Department of Medical Oncology, Kobe City Medical Center General Hospital
                                          
~10 Minute Break~
  
6. Consensus   16:15~17:25
    “Consensus on Anticancer Drug Treatment of HER2 Negative Recurrent Breast Cancer”
Presiding: Dr. Shiro Imai, Department of General Surgery, Kurashiki Central Hospital
                Dr. Hiroyasu Yamashiro, Department of Breast Surgery, Tenri Hospital
                           

Institution Report (10 minute each)
1)    Dr. Tatsushi Kato, Department of Surgery, Yamato Takada Municipal Hospital
                   
2)    Dr. Hiroshi Yoshibayashi, Department of Breast Surgery, Japanese Red Cross Wakayama Medical Center
           
~10 Minute Break~

7. Special Lecture 17:35~18:25 “What is the Anticancer Drug that OS extends in Advanced/Recurrent Breast Cancer?”

Moderator: Dr. Hironori Kato, Department of Breast Surgery, Kobe City Medical Center General Hospital

Lecturer: Dr. Shigehira Saji, Department of Medical Oncology, Fukushima Medical University School of Medicine


8. “Applicability of Preoperative AL+Trastuzumab Treatment for Postmenopausal Breast Cancer     with ER Positive HER2 Positive” 18:25 ~18:35
        Dr. Hironori Kato, Department of Breast Surgery,Kobe City Medical Center General Hospital Department of Breast Surgery  
                                 
9. Closing Address 18:35~18:40       Dr. Takashi Inamoto, Tenri Health Care University
   
* Please pay the participation fee of 3,000 Yen on the day
* Information Exchange Meeting is scheduled after the conference

[Co-host]
Kyoto Breast Cancer Consensus Conference
Ministry of Education, Culture, Sports, Science and Technology ‘Cancer Professional Training Base Promotion Plan’
Eisai Co., Ltd